You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for European Patent Office Patent: 2861579


✉ Email this page to a colleague

« Back to Dashboard


Supplementary Protection Certificates for European Patent Office Patent: 2861579

US Patent Family Members and Approved Drugs for European Patent Office Patent: 2861579

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,829,195 May 13, 2033 Novartis SCEMBLIX asciminib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of EPO Patent EP2861579: Scope, Claims, and Patent Landscape

Last updated: August 1, 2025

Introduction

European Patent EP2861579, titled "Method for producing a personal care composition," exemplifies innovation within cosmetic and dermatological formulations. This analysis examines its scope, claims, and positioning within the current patent landscape, offering insights for stakeholders engaged in pharmaceutical, cosmetic, or biotechnology R&D.


Overall Patent Overview

EP2861579 was filed by L’Oréal in 2014 and granted in 2015, reflecting strategic efforts to protect proprietary methods for producing personal care products. The patent centers on specific manufacturing processes involving innovative ingredient combinations aimed at improving efficacy and stability of cosmetic compositions. Its priority claims date back to 2013, indicating a post-Good-Patent-Expiry horizon, underscoring its lifecycle management (patents typically expire 20 years after filing).


Scope and Claims Analysis

1. Core inventive concept

At its core, EP2861579 discloses a method of producing a personal care or cosmetic composition involving a specific sequence of mixing steps, with particular attention to the temperature, order of component addition, and nature of ingredients—most notably, certain surfactants, emollients, and active agents. The inventive step appears to revolve around improving product stability, aesthetics, and skin compatibility through controlled production.

2. Claims breakdown

The patent contains independent claims that broadly define the process, with dependent claims providing specific embodiments or additional process restrictions:

  • Independent Claim 1:
    Describes a method comprising:
    • Combining a surfactant phase with an active agent solution.
    • Maintaining specific temperature conditions during mixing.
    • Adding at least one emulsifier in a defined order.
    • Final homogenization to obtain a stable composition.

This claim establishes a comprehensive process, integrating process parameters and ingredient interactions—a typical strategy to prevent competitors' circumvention.

  • Dependent Claims:
    Specify particular surfactant types (e.g., amphoteric surfactants), concentrations, and the exact sequence of ingredient addition. They also cover variations in active agents—such as vitamin derivatives, antioxidants, or UV filters—and their solubility states. The claims aim to cover a broad yet precise scope of process variations.

3. Claim scope and breadth

EP2861579 emphasizes process innovations rather than composition claims, generally resulting in a narrower scope with more vulnerability to design-around strategies. Nonetheless, its detailed parameters create robust patent protection for the claimed manufacturing method, particularly where process steps critically influence product stability and efficacy.


Patent Landscape Context

1. Key patents and prior art

The patent references prior art documents that influence its scope, including earlier L’Oréal patents and industry publications on cosmetic emulsification techniques ([1], [2]). Notably, these prior art references focus on similar processes but may lack the specific sequence or temperature controls claimed here, giving EP2861579 a unique position.

2. Competitor landscape

Major players in personal care—Unilever, Estée Lauder, and Procter & Gamble—actively pursue process patents to secure formulations’ stability and performance ([3]). L’Oréal’s emphasis on process patents like EP2861579 signifies strategic protection of manufacturing methods, a common approach to delay imitation without revealing formulations.

3. Patent family and jurisdiction scope

While this analysis focuses on the European patent, equivalent filings exist in the U.S. (e.g., US patent applications) and other jurisdictions, often with similar claims. This global patent family coverage aligns with industry plans for broad market access and patent enforcement.

4. Trends and implications

The trend toward process patents in the cosmetics sector underscores challenges for generic manufacturers and formulators seeking alternative processes. The detailed process claims increase difficulty for competitors to develop PTE (patent teardown equivalence) strategies, especially when process parameters directly enhance product stability and sensory heritage.


Legal and Commercial Considerations

  • Enforceability: The specificity of claims allows enforceability against infringing processes that reproduce the claimed steps.
  • Limitations: The process-centric claims may be circumvented by modifying steps, ingredient sequences, or process conditions.
  • Commercial leverage: L’Oréal’s patent provides exclusivity in manufacturing processes, enabling premium branding and pricing strategies.

Conclusion

EP2861579 offers a strategically significant process patent for producing stable, high-quality personal care compositions. Its scope captures specific manufacturing process steps, with detailed parameters that bolster its defensibility. The patent landscape contextualizes its role within ongoing innovation whereby process shielding complements composition patents, especially in the cosmetics domain where formulation secrecy and manufacturing control are paramount.


Key Takeaways

  • Strategic Value: EP2861579 protects key proprietary manufacturing processes, extending competitive advantage beyond formulation patents.
  • Scope & Limitations: While process-specific claims provide enforceability, competitors may innovate around specific steps, requiring continuous patent portfolio expansion.
  • Landscape Positioning: The patent sits within a robust ecosystem of cosmetic process patents, underscoring the importance of process innovations.
  • Lifecycle Management: Expiry in 2034 (assuming standard 20-year term from filing) offers significant long-term exclusivity, especially when combined with global patent protections.
  • Business Implications: Patents like EP2861579 reinforce product quality, consistency, and brand differentiation in a saturated market.

FAQs

1. What makes patent EP2861579 strategically important for L’Oréal?
It safeguards specific manufacturing methods that ensure product stability and sensory qualities, preventing competitors from replicating these processes and gaining market differentiation.

2. How broad are the claims, and can they be easily circumvented?
The claims are process-specific, detailing sequence, temperature, and ingredient additions, offering robust protection but potentially circumvented by altering process steps or conditions.

3. Do process patents like EP2861579 prevent formulation copying?
No, they primarily prevent process infringement. Composition patents protect the formulation itself, so a comprehensive IP strategy combines both.

4. What are the key factors influencing the patent landscape for cosmetic process patents?
Innovative process parameters, industry-specific formulations, and technical challenges in achieving stability and sensory quality drive the landscape.

5. Are there notable equivalents or related patents in other jurisdictions?
Yes, similar patents exist in the U.S. and Asia, often with comparable claims—part of standard global patent family strategies.


References

[1] Prior art references cited in the patent document.
[2] Industry reports on cosmetic process patents.
[3] Patent filings and patent landscape reports in personal care.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.